By Katherine Hamilton
Lantheus Holdings shares rose after its adjusted earnings for the fourth quarter and 2025 outlook estimates were higher than expected.
The stock climbed 20%, to $96.36. The stock has gained about half its value over the past year.
The Bedford, Mass., radiopharmaceutical company said it expects adjusted earnings per share to be $7 to $7.20 a share in 2025. Analysts polled by FactSet were expecting $6.98 a share.
It also guided for $1.55 billion to $1.61 billion in revenue this year, compared with the $1.61 billion forecast by Wall Street.
For the fourth quarter, Lantheus posted a loss of $11.8 million, or 17 cents a share, compared with a profit of $103.4 million, or $1.47 a share, the prior year. Adjusted earnings per share of $1.59 were 5 cents more than analysts expected.
Revenue rose about 11%, to $391.1 million, ahead of analysts' expectations of $376.1 million.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
February 26, 2025 11:59 ET (16:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.